Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04778449 · ClinicalTrials.gov registry record
Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma
A clinical trial of Cutaneous Melanoma, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT04778449: Recruiting study of Cutaneous Melanoma, sponsored by M.D. Anderson Cancer Center.
NCT04778449 is a study of Cutaneous Melanoma that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 5,000 participants, above the 200-participant average among 30 other Cutaneous Melanoma trials with a reported enrollment target (2400% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04778449, a study of Cutaneous Melanoma, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This study investigates the extent to which lifestyle factors including mental health, social support, diet, and exercise are associated with quality of life and melanoma patient outcomes. Knowledge gained from this study may be used to guide the design of prospective clinical trials of lifestyle interventions to improve the outcomes of melanoma patients and assist doctors in counseling their patients.
Primary Outcome
Will be assessed using the Centers for Epidemiologic Studies - Depression. Lifetime history of Major Depressive Disorder (MDD) will be measured using the two cardinal items from the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders-IV Disorder. Multivariate methods, including repeated measures analyses, will be employed to further explore the potential changes in the measures over time.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Medical Chart Review
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2015-08-26 |
| Est. Completion | 2026-12-31 |
What NCT04778449 shows while recruiting
NCT04778449 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 200-participant average among 30 other Cutaneous Melanoma trials with a reported enrollment target (2400% higher).
The record links to 1 condition, with Cutaneous Melanoma appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire Administration is the first listed.
NCT04778449 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04778449 about?
NCT04778449 is a clinical study titled "Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma". This study investigates the extent to which lifestyle factors including mental health, social support, diet, and exercise are associated with quality of life and melanoma patient outcomes. Knowledge gained from this study may be used to guide the design of prospective clinical trials of lifestyle in...
What is the current status of trial NCT04778449?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2015-08-26. Estimated completion is 2026-12-31.
What conditions does trial NCT04778449 study?
This clinical trial studies the following conditions: Cutaneous Melanoma.
What interventions are being tested in trial NCT04778449?
The interventions under investigation include: Questionnaire Administration (OTHER), Medical Chart Review (OTHER).
Who is sponsoring clinical trial NCT04778449?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04778449 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cutaneous Melanoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04778449's enrollment target sits among peer trials
5,000 1st of 30 higher than 30 of 30 other Cutaneous Melanoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cutaneous Melanoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
RECRUITING · Phase 1
-
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
-
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
RECRUITING · Phase 2
-
ACTengine® IMA203 Combined With mRNA-4203
RECRUITING · Phase 1
-
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
RECRUITING · Phase 1
-
EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI